Atlas Trials

Bioeq GmbH

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Bioeq GmbH

RecordFirmDate
A Double-blind Study to Compare the Efficacy, Safety, and Immunogenicity of the Proposed Biosimilar Ustekinumab FYB202 to Stelara® in Patients With Moderate-to-Severe Plaque Psoriasis (NCT04595409)Bioeq GmbH2020-11-09
Efficacy and Safety of the Aflibercept FYB203 Biosimilar in Comparison to Eylea® in Patients With Neovascular Age-Related Macular Degeneration (NCT04522167)Bioeq GmbH2020-07-21

Track Bioeq GmbH automatically

Every clearance here is in the API, with alerts when new ones post.